FDA Drug Application (021224) for RAZADYNE by JANSSEN PHARMS

Back to FDA Applications sponsored by JANSSEN PHARMS

Application Number021224
Product Number001
FormSOLUTION;ORAL
Dosage4MG/ML
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameRAZADYNE
Active IngredientGALANTAMINE HYDROBROMIDE

Active IngredientCount
List of drugs with Active Ingredient GALANTAMINE HYDROBROMIDE3


Back to FDA Applications sponsored by JANSSEN PHARMS